5 Biotech Stocks under $10

The line up consists of Acadia Pharmaceuticals Inc (ACAD), Cambrex Corp (CBM), Neurocrine Biosciences Inc (NBIX), Pdl Biopharma Inc (PDLI) and Santarus Inc (SNTS).

Here is the screen criteria, with the goal of finding a profitable company that has growth potential in the future:

Sector = Healthcare
Industry = Biotechnology
Current Volume >100k
Country = USA
Price < $10
P/E > 0 (Profitable)
EPS Growth next 5 years > 10%


Over the past 12 months Acadia Pharmaceuticals Inc (ACAD) shares have traded between $0.9 and its 52-week high of $3.3.  Acadia Pharmaceuticals Inc shares are now trading with a P/E Ratio of 3.5 and EPS of 0.41.



Over the past 12 months Cambrex Corp (CBM) shares have traded between $3.87 and its 52-week high of $8.12.  Cambrex Corp shares are now trading with a P/E Ratio of 14.2 and EPS of 0.5.



Over the past 12 months Neurocrine Biosciences Inc (NBIX) shares have traded between $5.42 and its 52-week high of $8.92.  Neurocrine Biosciences Inc shares are now trading with a P/E Ratio of 11.8 and EPS of 0.69.



Over the past 12 months Pdl Biopharma Inc (PDLI) shares have traded between $4.66 and its 52-week high of $6.7.  Pdl Biopharma Inc shares are now trading with a P/E Ratio of 8.7 and EPS of 0.74.



Over the past 12 months Santarus Inc (SNTS) shares have traded between $2.4 and its 52-week high of $4.74.  Santarus Inc shares are now trading with a P/E Ratio of 516.4 and EPS of 0.01.